Details of the Drug Reposition

General Information of This Drug (ID: DM6ZOUV)

Drug Name
Clazakizumab   DM6ZOUV
Synonyms Clazakizumab; ALD518; CHEMBL2108589; BMS-945429
Therapeutic Class
Antiviral Agents
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Crohn disease DIS2C5Q8 DD70 Phase 2 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02015520) Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)